Stay updated on AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.

Latest updates to the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label on the page updated to v3.5.2, replacing the prior v3.5.0. This is a metadata update and does not affect study details or outcomes.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Squamous Cell Carcinoma of Head and Neck as a listed condition and added the Genetic and Rare Diseases Information Center as a resources link.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 was added. The government-funding notice and Revision: v3.4.1 were removed from the page.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center’s current operating status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.